Blackstone bets a billion on PTC Therapeutics; Grant Ave brings in Brian Berkin for healthcare expertise

Blackstone inks deal with PTC Therapeutics.

28 October 2022•5 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.